NCT06720519View on ClinicalTrials.gov

Molecular Panel Evaluation for Diagnosis of Infections of the Central Nervosous System

Active, not recruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

October 17, 2024

Study Completion Date

April 17, 2025

Conditions
Infections Nervous System
Interventions
DIAGNOSTIC_TEST

QIAstat-Dx®Meningitis/Encephalite Panel

"The analytical sensitivity of the test is assessed by comparing the results obtained with those known from routine diagnostic tests.~For viruses only, the semi-quantitative value of Ct is also evaluated with the viral load provided by qPCR."

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06720519 - Molecular Panel Evaluation for Diagnosis of Infections of the Central Nervosous System | Biotech Hunter | Biotech Hunter